Anesthesia in neurovascular diseases

Authors

  • Germán David Artunduaga Antezana
  • Ruth Vanesa Barrientos Medina

DOI:

https://doi.org/10.52428/20756208.v12i31.505

Keywords:

Neurovascular disease, Anesthesia, Surgical anesthetic risk

Abstract

The neurovascular diseases are entities of genetic origin and with triggers such as arterial hypertension, smoking, alcoholism, diabetes mellitus, dyslipidemia among others. The most frequent neurovascular pathology is cerebral aneurysm and very rarely arteriovenous malformations.

The rupture of a cerebral aneurysm has a very high mortality at the moment of the rupture and those who survive have a high incidence of physical and socio-economic consequences for the patient and family members. The adequate anesthetic management can influence in improving the perioperative survival of these patients. Perioperative anesthetic monitoring includes sp02, expired C02 (etC02), ECG, noninvasive blood pressure (NIBP), neuromuscular relaxation monitoring, diuresis, invasive blood pressure (IAP), central venous catheter and central venous pressure. Anesthesia is based on a combination ofanesthetics (what is known as balanced genera/ anesthesia), although currently it is advisable to use a technique called Total Intravenous Anesthesia (TIVA) based exclusively on the administration of intravenous anesthetic agents such as propofol or thiopental sodium (hypnotic), remifentanyl or fentanyl (opiode) and atracurium or cisatracurium or rocuronium (muscle relaxant), administered in infusion pumps (manual or TCI) and orotracheal intubation.

The most important objectives are to maintain hemodynamic stability and adequate cerebral relaxation, as well as to facilitate adequate surgical exposure, rapid postoperative reczovery ifappropriate, or to pass the patient asleep and intubated to the intensive care unit in more complicated cases.

Downloads

Download data is not yet available.

References

Carrillo Esper, R, Castelazo Arredondo, JA. Neuroanestesiología y cuidados intensivos neurológicos. México: Editorial Alfil. Págs. 157 - 173. (2007).

Mineharu, Y, Inoue K, Inoue S, Yamada S, Nozaki K, Takenaka K, Hashimoto N, Koizumi A. Association analysis of common variants of ELN, NOS2A, APOE and ACE2 to intracranial aneurysm. Stroke 2006; 37(5):1 189-1 1 94.

Juvela S. Natural history of unruptured intracraneal aneurysm: risks for aneurysm formation, growth and ruptura. Acta Neurochir Suppl

Inagawa T. Risk factors for aneurysmal subarachnoid hemorrhage in patients in Izumo City, Japan. J. Neurosurg 2005; 102(1): 60-67.

Juvela S. Prehemorrhage risk factors for fatal intracraneal aneurysm ruptura. Stroke 2003; 34(8): 1852-1857.

Adrian W. Gelb. Perioperative Management of Neurovascular Diseases. Meeting- Refresher American Society of Anesthesiologist 2015. San Francisco, California. USA. (2015).

Niño de Mejía MC, Ferrer Z. LE. Neuroanestesia. Enfoque perioperatorio en el paciente neurológico. Colombia: Editorial Distribuna. Págs. 271 -283. (2005).

Cotrell JE, Patel P. Cottrell and Patel Neuroanesthesia. Sixth Edition. USA: Elsevier. Pag. 222 -247. (2017).

Carrillo Esper R, Castelazo Arredondo JA. Neuroanestesiología y cuidados intensivos neurológicos. México: Editorial Alfil. Págs. 157 - 173. (2007).

Niño de Mejía MC, Ferrer Z. LE. Neuroanestesia. Enfoque perioperatorio en el paciente neurológico. Colombia: Editorial Distribuna. Págs. 271 - 283. (2005).

Published

2017-12-30

How to Cite

Artunduaga Antezana, G. D., & Barrientos Medina, R. V. (2017). Anesthesia in neurovascular diseases. Revista De Investigación E Información En Salud, 12(31), 37–45. https://doi.org/10.52428/20756208.v12i31.505

Issue

Section

Artículos Originales